Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.16 is 104% above its 5-year average of -3.80, near the high end of its 5-year range (-6.62–0.16).
107.90% above its 12-month average of -2.02.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 2.61.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 31 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:30:35.046Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
0.16
EARNINGS PER SHARE (EPS) AVG TTM
-2.02
EARNINGS PER SHARE (EPS) AVG 3Y
-3.99
EARNINGS PER SHARE (EPS) AVG 5Y
-3.80
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+107.90%
CURRENT VS 3Y AVG
+104.01%
CURRENT VS 5Y AVG
+104.21%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Arvinas, Inc.
Market Cap
$473.59M
Earnings Per Share (EPS)
0.16
TTM Avg
-2.02
3Y Avg
-3.99
5Y Avg
-3.80
Market Cap
$473.56M
Earnings Per Share (EPS)
-0.04
TTM Avg
-0.10
3Y Avg
-0.16
5Y Avg
-0.22
Market Cap
$473.65M
Earnings Per Share (EPS)
-1.73
TTM Avg
-1.90
3Y Avg
-1.16
5Y Avg
-1.16
Market Cap
$471.45M
Earnings Per Share (EPS)
-1.99
TTM Avg
-0.88
3Y Avg
-1.91
5Y Avg
-1.95
Market Cap
$470.73M
Earnings Per Share (EPS)
-0.31
TTM Avg
-0.44
3Y Avg
-0.93
5Y Avg
-0.65
Market Cap
$467.56M
Earnings Per Share (EPS)
-0.56
TTM Avg
-0.89
3Y Avg
-1.18
5Y Avg
-1.13
Market Cap
$484.56M
Earnings Per Share (EPS)
0.52
TTM Avg
0.62
3Y Avg
0.43
5Y Avg
-0.09
Market Cap
$486.79M
Earnings Per Share (EPS)
-0.52
TTM Avg
-0.81
3Y Avg
-1.01
5Y Avg
-1.63
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arvinas, Inc. (ARVN) | $473.59M | 0.16 | -2.02 | -3.99 | -3.80 |
| Cerus Corporation (CERS)vs › | $473.56M | -0.04 | -0.10 | -0.16 | -0.22 |
| Contineum Therapeutics, Inc. (CTNM)vs › | $473.65M | -1.73 | -1.90 | -1.16 | -1.16 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $471.45M | -1.99 | -0.88 | -1.91 | -1.95 |
| Alpha Teknova, Inc. (TKNO)vs › | $470.73M | -0.31 | -0.44 | -0.93 | -0.65 |
| Kamada Ltd. (KMDA)vs › | $469.70M | 0.38 | 0.32 | 0.19 | 0.19 |
| Sight Sciences, Inc. (SGHT)vs › | $467.56M | -0.56 | -0.89 | -1.18 | -1.13 |
| Puma Biotechnology, Inc. (PBYI)vs › | $484.56M | 0.52 | 0.62 | 0.43 | -0.09 |
| Evolus, Inc. (EOLS)vs › | $486.79M | -0.52 | -0.81 | -1.01 | -1.63 |
| NRC Health (NRC)vs › | $457.83M | 0.25 | 0.79 | 1.03 | 1.18 |
Trailing EPS (TTM)
$0.16
Forward EPS (Est.)
$-0.04
P/E Ratio
45.9
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.28 |
| 2024-12-31 | -2.77 |
| 2023-12-31 | -6.62 |
| 2022-12-31 | -5.31 |
| 2021-12-31 | -3.82 |
| 2020-12-31 | -3.02 |
| 2019-12-31 | -1.89 |
| 2018-12-31 | -1.31 |
| 2017-12-31 | -1.38 |
| 2016-12-31 | -7.56 |
